Veracyte Announces Second Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- S&P 500 ends higher as traders shift from AI to healthcare
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
- Vertiv shares fall on analyst downgrades and options bets
- S&P 500 ends higher as traders shift from AI to healthcare
- Rocket Lab USA (RKLB) Reiterated at Overweight by Cantor Fitzgerald as Neutron Launch Moved to Next Year
- Caterpillar names Derrick York to lead Resource Industries
- Intel shares drop on foundry risks, sector pressures
Veracyte (VCYT) PT Lowered to $10 at Piper Jaffray Following Results
August 4, 2016 7:18 AM EDTPiper Jaffray analyst William Quirk lowered his price target on Veracyte, Inc (NASDAQ: VCYT) to $10.00 (from $12.00) but maitnained a Overweight on the stock following results.
Quirk commented, "Veracyte reported a 23% yoy revenue increase to $14.7M, ~in line with the Street. EPS of ($0.40)... More
Veracyte (VCYT) Misses Q2 EPS by 7c
August 3, 2016 4:06 PM EDTVeracyte (NASDAQ: VCYT) reported Q2 EPS of ($0.40), $0.07 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $14.68 million versus the consensus estimate of $14.81 million.
For earnings history and earnings-related data on Veracyte (VCYT) click here.
... More


